Chris Cassella concentrates his practice primarily on complex pharmaceutical patent litigation matters arising under the Hatch-Waxman Amendments to the Patent Act and the Federal Food, Drug and Cosmetic Act. His experience ranges from pre-litigation activities, including Paragraph IV Certifications, through initial filings, fact and expert discovery, claim construction, motion practice and pre-trial phases.
Chris Cassella concentrates his practice primarily on complex pharmaceutical patent litigation matters arising under the Hatch-Waxman Amendments to the Patent Act and the Federal Food, Drug and Cosmetic Act. His experience ranges from pre-litigation activities, including Paragraph IV Certifications, through initial filings, fact and expert discovery, claim construction, motion practice and pre-trial phases.
While in law school, in addition to five CALI Excellence for the Future Awards (given to the highest-scoring student in each law school class), Chris earned Brief Writing Honors in the Sherman Minton Moot Court Competition. He also served on the Executive Board of his law school's Intellectual Property Association and was a Senior Editor of the law school's journal, IP Theory. He has an advanced degree in biology as well as an undergraduate degree in biochemistry.
Chris is registered to practice in patent matters before the U.S. Patent and Trademark Office.
His experience includes:
magna cum laude
, Indiana University Maurer School of Law, 2017Order of the Coif
Senior Editor, IP Theory